scholarly journals Benefit of continuing trastuzumab beyond progression in her2-positive metastatic breast cancer (mbc) is independent of the chemotherapy partner: message from a single-centre retrospective study

The Breast ◽  
2011 ◽  
Vol 20 ◽  
pp. S46-S47
Author(s):  
Raffaella Palumbo ◽  
Federico Sottotetti ◽  
Antonio Bernardo ◽  
Maria Rosa Strada ◽  
Alberto Riccardi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Retrospective Study ◽  
Metastatic Breast ◽  
Single Centre ◽  
Her2 Positive

scholarly journals 286P Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study

2021 ◽  
Vol 32 ◽  
pp. S489
Author(s):  
C. Bigot ◽  
H. Bischoff ◽  
I. Chambrelant ◽  
M.F. Demarchi ◽  
T. Petit ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Retrospective Study ◽  
Metastatic Breast ◽  
Her2 Positive

Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 616-616
Author(s):  
Daniel Fontes Santos De Teive E Argolo ◽  
Lillian Mary Smyth ◽  
Neil M. Iyengar ◽  
Sujata Patil ◽  
Larry Norton ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Retrospective Study ◽  
Metastatic Breast ◽  
Second Line ◽  
Single Center ◽  
Her2 Positive ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document